The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
about
Codeine, alone and with paracetamol (acetaminophen), for cancer painImpact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer painThe therapeutic potential of cannabis and cannabinoidsAre cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic reviewMedical marijuana: clearing away the smokeCannabinoids in health and diseaseAdverse effects of medical cannabinoids: a systematic reviewThe endocannabinoid system as an emerging target of pharmacotherapyEndocannabinoids in the retina: from marijuana to neuroprotectionBreast cancer pain management - a review of current & novel therapiesOral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challengeMarijuana in the management of amyotrophic lateral sclerosis.Medical marijuana.The pharmacologic and clinical effects of medical cannabis.Therapeutic potential of cannabinoid medicines.Pharmacological actions and therapeutic uses of cannabis and cannabinoids.Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.Effects of 20 mg oral Δ(9) -tetrahydrocannabinol on the olfactory function of healthy volunteers.Cannabinoid-based medicines for neurological disorders--clinical evidence.The endocannabinoid system and cancer: therapeutic implication.The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applicationsAcute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.Cannabinoids in cancer pain management.Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet MonkeysCannabis and endocannabinoid modulators: Therapeutic promises and challenges.On the pharmacological properties of Delta9-tetrahydrocannabinol (THC).Cannabinoids:their role in pain and palliation.The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer painA randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic painThe cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanismsInteraction of the cannabinoid and opioid systems in the modulation of nociception.Role of cannabinoids in the treatment of pain and (painful) spasticity.Is there any clinically relevant cannabinoid-induced analgesia?Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain.Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Medical uses of marijuana (Cannabis sativa): fact or fallacy?
P2860
Q24193511-0D027AB6-8B51-4C20-AD32-CD111ED67164Q24194524-035FD71E-067F-4E6F-90E5-E516022237F5Q24600806-1C46D177-B131-4B41-95F0-40C81CBE8567Q24607880-5FC16E20-D372-49EB-A3D6-37B8DAFBD15EQ24617731-7A14E813-910E-4E58-9865-E584EFBE9EE3Q24633884-ED62FD58-CB4B-4CEC-BC87-24F314DF676CQ24644380-1D726742-A131-4F3B-8F17-DA15A058CA7FQ24648473-9FCF8F5D-C270-4530-9F5A-665E060CFB94Q24656049-3E0F484A-7C2A-49D2-BAAA-16F0823D2ECAQ27008950-C65A85F9-F287-4B32-BAC1-425FF6465B85Q33915426-207C210A-631B-4E69-A9D1-2867414D89F8Q34084721-3974C125-E10F-43B1-9B3A-FA9494D28DBFQ34188770-26A63654-678E-4B93-8459-C97DD5483559Q34326515-0C6E1765-57AD-42D0-9E04-73DCB9D740AEQ34368715-A6B6CF38-4133-444E-8461-B562451F3FC4Q34434597-E689A9E4-97F5-4ED3-B43E-1466476DF78DQ34490167-3D979031-D9CE-4D1B-B4F0-4FEEDA646C30Q34549363-F792D736-B181-4344-80D9-181DF7CFA225Q34570852-98C20549-81E4-4319-8B79-ABAAFFB1E45EQ34704890-FEB75685-01AA-47DF-88CD-FA577145DB61Q35193299-15F88400-D996-4D8E-B07B-485A16FF8DDCQ35921090-7B0478B3-26FA-4CC8-BE87-37B46B361137Q36015427-1FE35590-CED4-4A12-A13E-DCE0310CF181Q36341688-945E2F7A-D022-4860-A51D-B31B4532358FQ36576568-97E71D6E-ACEA-47AA-8758-ECA8C1870905Q36726650-9B64F18A-690F-42B0-B67B-D859B077D4E1Q36742000-90AE416F-CB67-49B7-B3CB-D2B88C269A87Q36892931-0286B516-5713-496E-AEE4-625A9A55FF2EQ36916114-690C7185-BD84-4ACE-BF3F-4953F24A4198Q37010970-BC5982F9-BA72-468F-8C38-A8D585485D4EQ37120771-40272F86-F05E-48FC-AC05-A09C4154FDD3Q37141496-C16529CA-72E9-43EC-BC9C-1E8D97B51763Q37182268-1E2C65B5-00A8-4602-9B7C-D346A36E3245Q37444813-38DE87A6-3BAC-420C-A573-87205CCA4099Q37818137-BD1BDC56-8CCA-4DAF-A384-4922E05AB4D3Q38003023-989E22DC-0411-4FFF-85DA-3BE27655A7FFQ38033572-5AFF9907-C767-4D72-A7D4-014FB5EC8391Q38287745-F798C888-0F74-4828-A006-CCF48A036528Q38503842-5B655848-EE6A-415F-B8EE-96A5C7690E34Q38540829-83B652F7-E547-4204-AE60-E32E473DDDCB
P2860
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
@en
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
@nl
type
label
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
@en
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
@nl
prefLabel
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
@en
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
@nl
P2093
P356
P1476
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
@en
P2093
P356
10.1002/CPT197518184
P407
P577
1975-07-01T00:00:00Z